Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 15Breast Neoplasms 14Sarcoma 11Squamous Cell Carcinoma of Head and Neck 10Glioblastoma 10Esophageal Neoplasms 9Rectal Neoplasms 8Stomach Neoplasms 7Urinary Bladder Neoplasms 6Neoplasms 6Carcinoma, Hepatocellular 6Pancreatic Neoplasms 5Colorectal Neoplasms 5Brain Neoplasms 5Oropharyngeal Neoplasms 4Lung Neoplasms 4Hypopharyngeal Neoplasms 4Head and Neck Neoplasms 4Glioma 4Recurrence 3Prostatic Neoplasms 3Parkinson Disease 4, Autosomal Dominant Lewy Body 3Neoplasm Metastasis 3Mouth Neoplasms 3Melanoma 3Colonic Neoplasms 3Astrocytoma 3Triple Negative Breast Neoplasms 2Thyroid Neoplasms 2Skin Neoplasms 2

Interventions

Diathermy 6Radiotherapy 2Surgical Procedures, Operative 1Solutions 1Saline Solution 1Patient Reported Outcome Measures 1Paclitaxel 1Immunotherapy 1Ifosfamide 1Hyperthermia, Induced 1Hydrogen Peroxide 1Doxorubicin 1Dacarbazine 1Cryotherapy 1Carboplatin 1AC protocol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hyperthermia × Surgical Procedures, Operative × 1 year × Clear all
NCT06835049 2025-12-30

TNT-HYPE

Swiss Cancer Institute

Phase 2 Recruiting
24 enrolled
Sarcoma

Hyperthermia, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡